MercadoLibre, Inc.
$103.19B- Market cap
- $100.30B
- Debt
- +$9.19B
- Cash
- −$6.30B
Capital structure 92% equity / 8% debt · EV / Revenue 3.57x · EV / EBITDA 29.81x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MELI stock price vs SRPT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SRPT's multiple
Needs SRPT P/E.
Implied fair value · at MELI's multiple
Needs EPS (TTM) is negative, MELI P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: MELI FY 2025 (ended Dec 31, 2025) · SRPT FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 92% equity / 8% debt · EV / Revenue 3.57x · EV / EBITDA 29.81x
Capital structure 74% equity / 26% debt · EV / Revenue 1.03x
MELI carries the larger enterprise value at $103.19B against $2.27B; SRPT trades on the lower EV / Revenue multiple (1.03x vs 3.57x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MercadoLibre, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
SAREPTA THERAPEUTICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.36x
0.73x
Net debt / EBITDA
Leverage against operating earnings
0.84x
0.17x
Cash and equivalents
Liquid reserves on the balance sheet
$6.30B
$939.65M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMAZON COM INC
MELI vs AMZN
DoorDash, Inc.
MELI vs DASH
Sea Ltd
MELI vs SE
EBAY INC
MELI vs EBAY
PDD Holdings Inc.
MELI vs PDD
JD.com, Inc.
MELI vs JD
AMGEN INC
MELI vs AMGN
BIOMARIN PHARMACEUTICAL INC
MELI vs BMRN
Replimune Group, Inc.
MELI vs REPL
PTC THERAPEUTICS, INC.
MELI vs PTCT
$9.19B
$828.97M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.